Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $87,890 - $108,885
-8,500 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$8.57 - $12.69 $4.29 Million - $6.35 Million
-500,000 Reduced 98.33%
8,500 $77,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $819,307 - $1.32 Million
-100,900 Reduced 16.56%
508,500 $6.27 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $4.08 Million - $8.2 Million
609,400 New
609,400 $5.47 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.